Kyverna Therapeutics Inc (KYTX) PT Raised to $27 at Wells Fargo
Tweet Send to a Friend
Wells Fargo analyst Derek Archila raised the price target on Kyverna Therapeutics Inc (NASDAQ: KYTX) to $27.00 (from $24.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
